Delivery of a clinical genomics service.
Over the past five years, next generation sequencing has revolutionised the discovery of genes responsible for rare inherited diseases previously resistant to traditional discovery techniques. This review considers how this new technology is being introduced into clinical practice to aid diagnosis and improve the clinical management of individuals and families affected by rare diseases where access to genetic testing was previously limited. We compare and contrast the different approaches that have been adopted including panel based tests, exome and genome sequencing. We provide insights from our own clinical practice demonstrating the challenges and benefits of this new technology.
Manchester Centre for Genomic Medicine, University of Manchester, Manchester, M13 9WL, UK. William.newman@manchester.ac.uk.
William G
WG
Newman
Manchester Centre for Genomic Medicine, University of Manchester, Manchester, M13 9WL, UK. Graeme.black@manchester.ac.uk.
Graeme C
GC
Black